Chinese English Germany Japanese

Shandong Aisha Technology Co. LTD회사는 제품 목록을 제공합니다.

회사 명:Shandong Aisha Technology Co. LTD
전화:-
이메일:sdaskj123@163.com
국적:China
URL: https://www.chemicalbook.com/supplier/24695235/
총 제품 수:106
1 2

제품 카탈로그

Olmesartan144689-24-7C24H26N6O3
OlmesartanEPImpurityB올메사르탄락톤불순물849206-43-5C24H24N6O2
Olmesartan MedoxomiI Impurity C87956-26-2
Trityl olmesartan트리틸올메사르탄144690-92-6C48H44N6O6
Dehydro Olmesartan데하이드로올메사르탄172875-98-8C24H24N6O2
Olmesartan Medoxomil Impurity UOlMesartan에틸에스테르불순물144689-23-6C26H30N6O3
Ethyl4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate144689-93-0C12H20N2O3
Ethyl4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate144689-94-1C12H18N2O4
OlMesartan interMediate iMpurity IIOlMesartan중급iMpurityII144690-07-3C11H16N2O3
Olmesartan Impurity 582190488-06-1C12H22N2O2
4-(1-Hydroxy-1-methylpropyl)-2-propyl-1H-Imidazole-5-carboxylic acidethylester172875-53-5C13H22N2O3
4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid144690-04-0C10H16N2O3
4-(1-Methylethenyl)-2-propyl-1H-Imidazole-5-carboxylic acidethylester157356-73-5C12H18N2O2
5-Thiazolecarboxylic acid, 2-[3-(ethoxycarbonyl)-4-(2-methylpropoxy)phenyl]-4-methyl-2476465-11-7C18H21NO5S
Febuxostat Impurity 7Febuxostat불순물71350352-70-3C16H18N2O4S
Febuxostat Impurity 6Febuxostat불순물61271738-74-9C18H22N2O4S
Febuxostat Impurity 1301643131-93-4C20H25NO5S
Febuxostat Impurity 14Febuxostat불순물141335202-60-2C15H16N2OS
Methyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate923942-34-1C17H18N2O3S
Febuxostat Descyano ImpurityFebuxostatDescyano불순물1206550-99-3C15H17NO3S
2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid407582-48-3C12H8N2O3S
Ethyl2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate160844-75-7C18H20N2O3S
2-(2-Hydroxyphenyl)-4-methyl-5-thiazolecarboxylic acid ethyl ester2-(2-하이드록시페닐)-4-메틸-5-티아졸카르복실산에틸에스테르118485-48-6C13H13NO3S
4-Hydroxyisophthalonitrile34133-58-9C8H4N2O
Olmesartan intermediate impurity IV4-(1-메톡시-1-메틸에틸)-2-프로필-1H-이미다졸-5-카르복실산에틸에스테르1092980-84-1C13H22N2O3
Olmesartan Impurity 9849206-42-4C10H14N2O2
2-[3-(AMinocarbonyl)-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid1239233-86-3C16H18N2O4S
2-[3-Carboxy-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid1239233-87-4C16H17NO5S
Febuxostat Impurity 8Febuxostat불순물8144060-62-8C16H17NO4S
5-(5-(ethoxycarbonyl)-4-methylthiazol-2-yl)-2-isobutoxybenzoic acid2095166-41-7C18H21NO5S
FeBuxostat Impurity 181312815-35-2C12H9NO4S
ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE161798-03-4C18H21NO4S
ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5- carboxylate2073891-59-3C15H13NO5S
Febuxostat Impurity 32 HCl1267681-15-1C12H11NO3S
N-DesMethyl DiphenhydraMine Hydrochloride53499-40-4C16H20ClNO
methyl (Z)-2-(2-nitrosobenzylidene)-3-oxobutanoate39562-27-1C12H11NO5
dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarb oxylate21829-09-4C17H18N2O6
Nitrendipine EP Impurity C21829-28-7C19H22N2O6
Dehydro Nifedipine N-Oxide디하이드로니페디핀N-옥사이드88434-69-9C17H16N2O7
Nifedipine디메틸1,4-디히드로-2,6-디메틸피리딘-3,5-디카르복실레이트17438-14-1C11H15NO4
Nifedipine Impurity 2180742-13-8C19H18N4O6
Dehydronitrosonifedipine50428-14-3C17H16N2O5
5-(methoxycarbonyl)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydrop yridine-3-carboxylic acid74936-71-3C16H16N2O6
vildagliptin Impurity R1803168-09-3C7H8Cl2N2O
vildagliptin Impurity F1789703-36-1C17H24N2O3
Nifedipine Impurity 780742-11-6C19H18N4O6
3-ethyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine- 3,5-dicarboxylate53055-15-5C18H20N2O6
m-NifedipineM-니페디핀21881-77-6C17H18N2O6
DehydroNifedipine67035-22-7C17H16N2O6
Norfloxacin Impurity 6126192-88-9C21H15N5O6
vildagliptin Impurity E1789703-37-2C17H25N3O2
diethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5- dicarboxylate21829-26-5C19H22N2O6
Nifedipine Impurity E114709-68-1C16H17N3O5
Vildagliptin carboxy acid metabolite565453-40-9C17H26N2O4
Cerium silicide12014-85-6CeSi2
Nonivamide2444-46-4C17H27NO3
4-CHLOROPHTHALIC ACID MONOSODIUM SALT4-클로로프탈 산, 모노나트륨 염56047-23-5C8H6ClNaO4
1 2
Copyright 2019 © ChemicalBook. All rights reserved